The company has established a complete pharmaceutical industry chain, achieved complete product route coverage of nitroimidazole antimicrobials and anti-herpes virus drugs from starting materials and key intermediates to APIs, and has become one of the world's major suppliers of nitroimidazole antibacterial raw materials and intermediates, anti-herpes virus raw materials and intermediates, and penicillin-type antimicrobial intermediates, and leading the core product market share industry. It is mainly engaged in R&D, production and sales of organic chemical raw materials, pharmaceutical intermediates, APIs, new energy sources and pharmaceutical preparations. The main products include glyoxal, glyoxylic acid, 2-methyl-5-nitroimidazole, metronidazole, guanine, lithium hexafluorophosphate, and pharmaceutical preparations. Corporate honors: It has successively won honorary titles such as “China's Quality AAAA Credit Enterprise”, “China's Top 100 Chemical and Pharmaceutical Industry Industrial Enterprises with Comprehensive Strength”, “Top 100 Chinese Pharmaceutical Enterprises”, “Hubei Province's Top 100 Private Enterprise Manufacturing Companies”, and “Hubei Pharmaceutical Industry Top 10 Producers and High Quality API Product Brands”.
No Data